SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
HALOZYME THERAPEUTICS, INC.
@HALO_InsiderForm 4 Filing: Torley Helen Sells $176,601.243 of $HALO
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
HALOZYME THERAPEUTICS, INC.
Ticker: $HALO
Transaction Value
$176,601.243
Price/Share: $45.92
transaction date
2026-07-08
Shares: 3,846
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Torley Helen, holds the title of PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC..
On 2026-07-08, the insider transacted 3,846 shares.The shares were transacted at a weighted average price of $45.92 per share, resulting in a total market-relevant value of $176,601.243.
Executive Summary Summary
Torley Helen (PRESIDENT AND CEO) sold $177K of $HALO
Post-Transaction Position: 767,780 shares
SEC Accession No: 0001159036-26-000100 (CIK: 1528185)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.